Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The Journal of Experimental Medicine|June 16, 2020
Layilin augments integrin activation to promote antitumor immunityKelly M Mahuron, Joshua M Moreau, Jeff E Glasgow, et al.The Journal of Experimental Medicine|March 2, 2021
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichmentKristen E Pauken, Osmaan Shahid, Kaitlyn A Lagattuta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in MelanomaAdil I Daud, Jedd D Wolchok, Caroline Robert, et al.Immunity|December 16, 2018
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, et al.Nature Medicine|June 27, 2018
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironmentsKevin C Barry, Joy Hsu, Miranda L Broz, et al.European Journal of Cancer (Oxford, England : 1990)|December 28, 2020
Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanomaCaroline Robert, Wen-Jen Hwu, Omid Hamid, et al.The Journal of Investigative Dermatology|September 6, 2017
Distinct Patterns of Acral Melanoma Based on Site and Relative Sun ExposureAlexandra M Haugh, Bin Zhang, Victor L Quan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2020
Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent MelanomaAlain P Algazi, Christopher G Twitty, Katy K Tsai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic MelanomaDouglas B Johnson, Jennifer Bordeaux, Ju Young Kim, et al.Cell|December 28, 2021
Discovering dominant tumor immune archetypes in a pan-cancer censusAlexis J Combes, Bushra Samad, Jessica Tsui, et al.Pageof 8